Polaryx Therapeutics, Inc. Common Stock (PLYX) Interest Coverage Ratio: History & Chart

Polaryx Therapeutics, Inc. Common Stock(PLYX)

Biotechnology · Paramus, NJ

$2.09+0.02 (+0.97%)

Delayed quote: Oct 6, 2026, 2:44 PM EDT

About Polaryx Therapeutics, Inc. Common Stock

Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to advancing small-molecule therapies for lysosomal storage and neurodegenerative conditions. Its developmental pipeline includes a trio of promising candidates: PLX-100, which combines PLX-200 with an ancillary supplement, targeting late infantile neuronal ceroid lipofuscinosis (LINCL) and related forms of NCL. PLX-200, a repurposed compound already utilized to address various diseases in both adult and pediatric populations. And PLX-300, derived from an edible plant, which works by activating PPARa to enhance the production of transcription factor EB. The company, established in 2014, maintains its base of operations in Paramus, New Jersey.

Paramus, NJ

11 employees

polaryx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Alex Yang

View full financials

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Polaryx Therapeutics, Inc. Common Stock (PLYX)	$104.18M	N/A	N/A	N/A	N/A
Anixa Biosciences, Inc. (ANIX)vs ›	$104.45M	N/A	N/A	N/A	N/A
Definitive Healthcare Corp. (DH)vs ›	$105.20M	-1.82x	N/A	N/A	N/A
Black Diamond Therapeutics, Inc. (BDTX)vs ›	$103.43M	N/A	N/A	N/A	N/A
Vivani Medical, Inc. (VANI)vs ›	$108.66M	N/A	N/A	N/A	N/A
The Joint Corp. (JYNT)vs ›	$102.63M	N/A	2.91x	2.91x	2.91x
Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs ›	$106.61M	N/A	N/A	N/A	N/A
OnKure Therapeutics, Inc. (OKUR)vs ›	$102.46M	N/A	N/A	N/A	N/A
Immunic, Inc. (IMUX)vs ›	$107.06M	N/A	N/A	N/A	N/A
Outlook Therapeutics, Inc. (OTLK)vs ›	$108.05M	-236.86x	N/A	N/A	N/A

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

Polaryx Therapeutics, Inc. Common Stock (PLYX)

$104.18M

N/A

Anixa Biosciences, Inc. (ANIX)vs ›

$104.45M

N/A

Definitive Healthcare Corp. (DH)vs ›

$105.20M